ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMFlussi di cassa derivanti dalle attività di investimento20 M-527 M-288 M-4.12 B891 M-4.05 BLiquidità derivante dalle attività di finanziamento-3.67 B-102 M-991 M-632 M3.53 B1.8 BLiquidità libera2.81 B361 M1.1 B1.83 B2.99 B6.29 B
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD.
It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion.
Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain.